刺激性腸症候群の患者における新たな症状サブグループが,二次および三次医療における医療利用と関連しています
Vivek C Goodoory1,2, Mais Khasawneh1,2, Christy Riggott1,2
1Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Alimentary pharmacology & therapeutics
|February 19, 2026
まとめ
ラテンクラス分析では,より高い心理的負担,より重度の症状,より高い生活の質の低下を経験する,刺激性腸症候群 (IBS) 患者グループが特定されました. また,これらのグループは,薬剤の処方箋の増加を含む, signicantly higher healthcare utilization を示しました.
科学分野:
- 胃腸内科 胃腸内科
- 心理学 心理学とは
- 医療サービス 研究 医療サービス
背景:
- 現在の刺激性腸症候群 (IBS) の分類は,心理的要因を無視して,腸の習慣に焦点を当てています.
- IBS患者の階層化について,検証された潜在クラス分析 (LCA) モデルが存在します.
研究 の 目的:
- 潜伏クラス分析 (LCA) モデルを二次および三次医療におけるIBS患者に適用する.
- LCAモデルがヘルスケア利用率を予測できるかどうかを判断する.
主な方法:
- IBS患者の参照集団にLCAを適用した.
- 胃腸症候群の重症度と心理的負担に基づいて,割り当てられたクラスターメンバーシップ.
- 12ヶ月間にわたる人口統計,症状の重症度,生活の質,医療利用の評価.
主要な成果:
- 379人の患者を募集し,そのうち249人がローマ4条の基準を満たした.
- 心理的負担が大きいクラスターでは,より重度のIBS症状 (IBS-SSS) と生活の質の低下が見られた.
- 心理的負担が高いクラスターは,退院率が低く,IBSの処方薬の割合が著しく高かった.
結論:
- LCAモデルは,IBS内の異なる患者グループを効果的に特定しました.
- 高い心理的負担のクラスターにある患者は,より重度の症状と生活の質の低下を示します.
- これらの特定されたグループは,縦断的なフォローアップにおいて, signicantly higher healthcare utilization を示しています.
関連する概念動画
Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Irritable Bowel Syndrome I: Introduction
1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Irritable Bowel Syndrome III: Medical and Nursing Management
989
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
Inflammatory Bowel Disease IV: Clinical Manifestations
33
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
33
Irritable Bowel Syndrome
36
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36


